Olivier George Selected Research

Hypersensitivity (Allergy)

1/2018	Compulsive-Like Sufentanil Vapor Self-Administration in Rats.
1/2015	Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier George Research Topics

Disease

13	Tobacco Use Disorder (Nicotine Dependence) 01/2022 - 07/2010
8	Alcoholism (Alcohol Abuse) 01/2022 - 10/2012
7	Substance-Related Disorders (Drug Abuse) 01/2022 - 09/2008
7	Hyperalgesia 10/2020 - 01/2015
6	Opioid-Related Disorders (Opiate Addiction) 05/2020 - 12/2013
5	Body Weight (Weight, Body) 03/2022 - 01/2017
5	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 04/2009
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022 - 12/2013
2	Inflammation (Inflammations) 11/2020 - 01/2020
2	Pain (Aches) 05/2020 - 01/2015
2	Hypersensitivity (Allergy) 01/2018 - 01/2015
1	Drug Overdose 01/2022
1	Chronic Pain 01/2020
1	Food Addiction 01/2020
1	Disease Progression 01/2020
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2018
1	Weight Gain 01/2018
1	Heroin Dependence (Heroin Abuse) 08/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Acute Pain 01/2017
1	Parkinson Disease (Parkinson's Disease) 07/2014
1	Neurocognitive Disorders (Clerambault Syndrome) 07/2014
1	Gliosis 07/2014
1	Huntington Disease (Huntington's Disease) 07/2014
1	Neuroinflammatory Diseases 07/2014
1	HIV Infections (HIV Infection) 07/2014

Drug/Important Bio-Agent (IBA)

18	Nicotine FDA Link 03/2022 - 07/2010
7	Opioid Analgesics (Opioids)IBA 01/2022 - 04/2009
7	Pharmaceutical PreparationsIBA 12/2018 - 09/2008
3	Ethanol (Ethyl Alcohol)IBA 01/2022 - 04/2009
3	Cocaine (Cocaine HCl)IBA 01/2022 - 01/2018
3	Oxycodone (Oxycontin)FDA LinkGeneric 05/2021 - 01/2019
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2021
2	LeptinIBA 01/2022 - 01/2020
2	Corticotropin-Releasing HormoneIBA 01/2020 - 01/2017
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 01/2017
2	Naloxone (Narcan)FDA LinkGeneric 01/2018 - 01/2017
2	CannabinoidsIBA 01/2018 - 04/2009
2	Heroin (Diamorphine)IBA 08/2017 - 12/2013
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2015 - 02/2011
2	Dynorphins (Dynorphin)IBA 01/2014 - 12/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	CannabidiolIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	paraform (paraformaldehyde)IBA 05/2021
1	Cannabinoid Receptor AgonistsIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Dopamine (Intropin)FDA LinkGeneric 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Caffeine (No Doz)FDA LinkGeneric 01/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	Dopamine D3 ReceptorsIBA 01/2019
1	VK4-116IBA 01/2019
1	EnzymesIBA 10/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2018
1	A-factor (Streptomyces)IBA 01/2018
1	OrexinsIBA 01/2018
1	Sufentanil (Sufenta)FDA LinkGeneric 01/2018
1	Therapeutic UsesIBA 08/2017
1	Calcium Channels (Calcium Channel)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2017
1	NociceptinIBA 01/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Mifepristone (RU 486)FDA Link 08/2015
1	CRF receptor type 1IBA 01/2015
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 07/2014
1	Proteins (Proteins, Gene)FDA Link 07/2014
1	NetrinsIBA 07/2014
1	Prostaglandin D2IBA 07/2014
1	InterferonsIBA 07/2014
1	Illicit Drugs (Recreational Drugs)IBA 12/2013
1	Opiate AlkaloidsIBA 12/2013
1	gamma-Aminobutyric Acid (GABA)IBA 10/2012
1	Varenicline (Chantix)FDA Link 02/2011
1	EndocannabinoidsIBA 04/2009

Therapy/Procedure

14	Self Administration (Administration, Self) 10/2020 - 02/2011
3	Therapeutics 01/2019 - 08/2017
1	Pain Management 01/2019
1	Biological Therapy 10/2018
1	Deep Brain Stimulation 08/2017